Press Releases

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and the Roche Institute for Research and Translational Medicine are strengthening their collaborative efforts. In 2009, the Institut Curie and Roche signed an initial...

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes. ...

As part of their “growth by acquisition” strategy, the pharmaceutical recruitment company; Pharma Consulting Group (PCG) has recently acquired Surrey based CSL Recruitment and Consulting Ltd. The acquisition, which took place on the 15th...

Clearside Biomedical Inc. a privately held ophthalmic company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases today announced that research on its proprietary retinal therapeutics platform will be presented at the 2013 Annual Meeting of...

  Hitachi Aloka Medical Ltd. delivers the message for Woman’s Healthcare “Clearly imaging a woman’s life Good things lie ahead” and announces the release of the new F37 at the upcoming ACOG Annual meeting in New Orleans. ...

Transgene SA a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases announced pre-clinical data obtained with its novel immunotherapeutic TG1050 to treat chronic hepatitis B infection (CHB)....

Baxter International Inc. today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research in Baltimore, Md. ...